Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach | |
Zhang, Zhichao; Song, Ting; Li, Xiangqian; Wu, Zhiyong; Feng, Yingang; Xie, Feibo; Liu, Chengwu; Qin, Jianquan; Chen, Hongbo | |
刊名 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY |
2013 | |
卷号 | 59页码:141-149 |
关键词 | Mcl-1 Small molecule inhibitor Fragment-based approach Anticancer |
ISSN号 | 0223-5234 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4537675 |
专题 | 大连理工大学 |
作者单位 | 1.Dalian Univ Technol, Sch Chem, State Key Lab Fine Chem, Dalian 116012, Peoples R China. 2.Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China. 3.Dalian Univ Technol, Sch Life Sci & Technol, Dalian 116024, Peoples R China. 4.Chinese Acad Sci, Qingdao Inst BioEnergy & Bioproc Technol, Qingdao 266101, Peoples R China. 5.Dalian Univ Technol, Sch Life Sci & Technol, Dalian 116024, Peoples R China. |
推荐引用方式 GB/T 7714 | Zhang, Zhichao,Song, Ting,Li, Xiangqian,et al. Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2013,59:141-149. |
APA | Zhang, Zhichao.,Song, Ting.,Li, Xiangqian.,Wu, Zhiyong.,Feng, Yingang.,...&Chen, Hongbo.(2013).Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,59,141-149. |
MLA | Zhang, Zhichao,et al."Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 59(2013):141-149. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论